Production (Stage)
Axsome Therapeutics, Inc.
AXSM
$105.07
$0.720.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.41M | -74.91M | -64.60M | -79.35M | -68.36M |
| Total Depreciation and Amortization | 2.13M | 2.07M | 2.06M | 1.99M | 1.83M |
| Total Amortization of Deferred Charges | 667.00K | 708.00K | 672.00K | 641.00K | 619.00K |
| Total Other Non-Cash Items | 23.39M | 33.13M | 38.21M | 23.72M | 19.25M |
| Change in Net Operating Assets | -10.15M | 12.80M | 5.03M | 22.88M | -6.81M |
| Cash from Operations | -43.38M | -26.20M | -18.63M | -30.11M | -53.47M |
| Capital Expenditure | -338.00K | -30.00K | -90.00K | -52.00K | -98.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -338.00K | -30.00K | -90.00K | -52.00K | -98.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -401.00K | -330.00K | -311.00K | -186.00K | -163.00K |
| Issuance of Common Stock | 36.69M | 17.57M | 33.39M | 18.01M | 2.50M |
| Repurchase of Common Stock | -4.34M | -533.00K | -473.00K | -1.33M | -1.62M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.68M | -2.46M | -2.20M | -2.11M | -1.91M |
| Cash from Financing | 29.27M | 14.24M | 30.41M | 14.38M | -1.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.44M | -11.99M | 11.68M | -15.78M | -54.75M |